Matthew Inlay, Ph.D.
Dr. Inlay also examine the role of the immune system in Alzheimer’s disease, and the impacts of neuroinflammation on immune cell recruitment and function in the brain. His second project is idiopathic thrombocytopenic purpura (IT), an autoimmune disease that destroys platelets. Overall, Dr. Inlay has mentored 5 Ph.D. students, 4 of whom have earned their Ph.D. and are currently employed in academia or industry in research-related positions. Two of his students, Ankita Shukla and Erika Varady, were supported by theT32 Immunology training grant during the last funding period. Dr. Shukla graduated in 2020 and is working in the biotechnology industry in Houston. Erika Varady graduated in July 2021 and is a staff researcher at Fate Therapeutics in San Diego. Luis Angel Ayala is a new student in the Inlay lab who is URM and TGE.